SCHEMBL16063256

SCHEMBL16063256

COP(=O)(COCCn1cnc2c(N)ncnc21)OCc1ccccc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 3/20 0.60
SLC22A6 Q4U2R8 2/20 0.60
ABCB11 O95342 1/20 0.58
POLA1 P09884 1/20 0.58
POLG P54098 1/20 0.58
FAP Q12884 1/20 0.58
ADORA2A P29274 3/20 0.54
LMNA P02545 2/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
HPGD P15428 1/20 0.51
NSD3 Q9BZ95 5/20 0.50
PI4KA P42356 1/20 0.50
PI4K2B Q8TCG2 1/20 0.50
PI4K2A Q9BTU6 1/20 0.50
PI4KB Q9UBF8 1/20 0.50
ENPP1 P22413 2/20 0.48
NSD2 O96028 4/20 0.47
NT5E P21589 1/20 0.47
ADORA2B P29275 1/20 0.45
ADORA1 P30542 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16063267 0.88 FGFR1 (0.68) FGFR1SLC22A6ABCB11POLA1POLG
SCHEMBL16063254 0.88 FGFR1 (0.68) FGFR1SLC22A6ABCB11POLA1POLG
SCHEMBL16063265 0.88 FGFR1 (0.68) FGFR1SLC22A6ABCB11POLA1POLG
SCHEMBL28797052 0.87 FGFR1 (0.74) FGFR1SLC22A6ABCB11POLA1POLG
SCHEMBL19929313 0.86 FGFR1 (0.62) FGFR1SLC22A6ABCB11POLA1POLG
SCHEMBL16020797 0.86 FGFR1 (0.66) FGFR1SLC22A6ABCB11POLA1POLG
SCHEMBL16062955 0.86 FGFR1 (0.66) FGFR1SLC22A6ABCB11POLA1POLG
SCHEMBL16062956 0.86 FGFR1 (0.66) FGFR1SLC22A6ABCB11POLA1POLG
SCHEMBL19470294 0.85 FGFR1 (0.70) FGFR1SLC22A6ABCB11POLA1POLG
SCHEMBL16063281 0.83 CYP3A4 (0.63) FAP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170304330-A1 ACYCLIC NUCLEOSIDE PHOSPHONATE DIESTERS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2017-10-26 US disclosed
US-8835630-B1 Acyclic nucleoside phosphonate diesters THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, A CALIFORNIA CORPORATION (US) 2014-09-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170304330-A1 ACYCLIC NUCLEOSIDE PHOSPHONATE DIESTERS NTPCR, PNP, TYMP FGFR1 3394/4885SLC22A6 1764/4885ABCB11 2382/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.